Poland· PL-100248062
Lipocynar
A silymarin product containing silybi mariani fructus extractum siccum + cynarae herbae extractum siccum, registered in Poland by Poznańskie Zakłady Zielarskie "Herbapol" S.A.. The same ATC class is registered in 5 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Silymarin is registered in 5 of 19 countries.
Countries holding a registration under ATC A05BA03 (silymarin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 5 of them publish a price we can compare per daily dose
Silymarin · ATC A05BA03
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Silybi mariani fructus extractum siccum + Cynarae herbae extractum siccum
- Manufacturer
- Poznańskie Zakłady Zielarskie "Herbapol" S.A.
- Country
- Poland (PL)
- ATC code
- A05BA03
- ATC class
- Silymarin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909990058211
- gtin05909990058228
- gtin05909990776320
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A05BA03
Silymarin, as other registers publish it.
- SwitzerlandAllsan Mariendistel, FilmtablettenBiomed AG
- SwitzerlandAllsan Mariendistel, FilmtablettenBiomed AG
- SwitzerlandAllsan Mariendistel, FilmtablettenBiomed AG
- SwitzerlandArkocaps Chardon Marie 390 mg nouvelle formule, gélulesArko Diffusion AG
- SwitzerlandArkocaps Chardon Marie 390 mg nouvelle formule, gélulesArko Diffusion AG
- CzechiaFLAVOBIONCHEPLAPHARM Arzneimittel GmbH, Greifswald
- CzechiaFLAVOBIONCHEPLAPHARM Arzneimittel GmbH, Greifswald
- PolandLagosaPharmapoint SA
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d14e6d0c-0698-4b24-8e5d-f0aa1945c34e GET /v1/drugs/d14e6d0c-0698-4b24-8e5d-f0aa1945c34e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "28,6 mg + 140 mg",
"packaging": "05909990058211 ¦ OTC ¦ Skasowane ¦ 9735\n60 draż. \n05909990058228 ¦ OTC ¦ 57606\n60 tabl.\n05909990776320 ¦ OTC ¦ 57607\n30 tabl.",
"substance": "Silybi mariani extractum siccum 28,6 mg; ekstrahent - metanol 90%, substancja pomocnicza - benzoesan sodu (<0,2%) + Cynarae herbae extractum siccum 140 mg; ekstrahent - woda",
"common_name": "Silybi mariani fructus extractum siccum + Cynarae herbae extractum siccum",
"pl_product_id": "100248062",
"pozwolenie_nr": "00582",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about silymarin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.